Filing Details
- Accession Number:
- 0001179110-11-012629
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-25 15:33:44
- Reporting Period:
- 2011-08-23
- Filing Date:
- 2011-08-25
- Accepted Time:
- 2011-08-25 14:33:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1055726 | Inovio Pharmaceuticals Inc. | INO | Surgical & Medical Instruments & Apparatus (3841) | 330024450 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1464549 | Joseph Jong Kim | C/O Inovio Pharmaceuticals, Inc. 11494 Sorrento Valley Road, Suite A San Diego CA 92121 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-08-23 | 20,000 | $0.65 | 20,000 | No | 4 | P | Indirect | By Son: JK1 |
Common Stock | Acquisiton | 2011-08-24 | 15,000 | $0.66 | 35,000 | No | 4 | P | Indirect | By Son: JK1 |
Common Stock | Acquisiton | 2011-08-24 | 35,000 | $0.67 | 35,000 | No | 4 | P | Indirect | By Daughter: EK |
Common Stock | Acquisiton | 2011-08-24 | 26,659 | $0.67 | 26,659 | No | 4 | P | Indirect | By Son: JK2 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Son: JK1 |
No | 4 | P | Indirect | By Son: JK1 |
No | 4 | P | Indirect | By Daughter: EK |
No | 4 | P | Indirect | By Son: JK2 |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 11,870,722 | Direct | |
Common Stock | 23,900 | Indirect | By Spouse |
Footnotes
- This Form 4 reflects the purchase of an aggregate of 96,659 shares of common stock of Inovio Pharmaceuticals, Inc. in the name of Joseph Kim's children. Column 5 of Table I now reflects the proper allocation between Dr. Kim's direct and indirect ownership of the shares listed.